FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

765 letters match. Newest first.

  1. Pico IV Inc.

    FDA warned Pico IV Inc. that its intravenous CBD product Pico IV is an unapproved new drug sold with drug claims.

    High risk
  2. C & A Naturistics

    C & A Naturistics sold unapproved new drugs online, including AK Forte with hidden acetaminophen and diclofenac.

    High risk
  3. Filler Lux dba Filler Lux USA

    FDA warned Filler Lux USA that it sells unapproved injectable lipolytic drugs online without FDA approval.

    High risk
  4. Fox Pharma LLC

    FDA warned Fox Pharma LLC that it sells unapproved injectable lipolytic drugs online.

    High risk
  5. Hyaluron Pen Store, LLC dba Glow Nest Beauty

    Glow Nest Beauty sells unapproved injectable fat-dissolving drugs online, FDA warned.

    High risk
  6. Julian Naya Beauty LLC

    FDA warned Julian Naya Beauty LLC that it sells six unapproved injectable fat-dissolving drugs on its website and social media.

    High risk
  7. Vivid-Scientific LLC

    Vivid-Scientific LLC sold injectable fat-dissolving products online as unapproved new drugs without FDA-approved applications.

    High risk
  8. Amazon.com, Inc.

    FDA warned Amazon over selling unapproved injectable fat-dissolving drugs on its website.

    High risk
  9. USApeptide.com

    FDA warns Germany-based USApeptide.com that it sells unapproved and misbranded semaglutide and tirzepatide drugs to U.S. consumers online.

    High risk
  10. TKTX USA

    FDA warned TKTX USA that its TKTX Numbing Creams are unapproved and misbranded drugs with lidocaine levels above OTC limits.

    High risk
  11. TKTX Numb Store

    FDA warned TKTX Numb Store that its lidocaine anesthetic creams are unapproved and misbranded drugs sold without a prescription.

    High risk
  12. TKTX Store

    FDA warns TKTX Store it sells unapproved lidocaine and prilocaine numbing creams online for tattooing and cosmetic procedures.

    High risk
  13. TKTX Numbing Cream USA

    FDA warned TKTX Numbing Cream USA that its lidocaine numbing creams are unapproved and misbranded new drugs.

    High risk
  14. AmWiner & Raphe Holdings, LLC dba rapheGenerics Corp

    FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.

    High risk
  15. Chara Biologics, Inc.

    FDA warns Chara Biologics over unapproved, unlicensed CharaExo, CharaCore, CharaOmni.

    High risk
  16. Mihon Corp. d/b/a VitalityVita and Boulla, LLC

    FDA warns Mihon Corp./Boulla that VitalityXtra, PeakMax, ZapMax and ZoomMax supplements contain hidden sildenafil and diclofenac and are unapproved, misbranded drugs.

    High risk
  17. Evolutionary Biologics Inc.

    FDA warned Evolutionary Biologics that its exosome and umbilical-cord products are unapproved new drugs and unlicensed biologics sold with disease-treatment claims.

    High risk
  18. www.weightcrunchshop.com

    FDA warned www.weightcrunchshop.com about selling unapproved and misbranded semaglutide and oxycodone drugs to U.S. consumers online.

    High risk
  19. INCELL Corporation LLC

    FDA warned INCELL Corporation for making an unapproved amniotic-fluid drug without validating its sterile manufacturing process.

    High risk
  20. XO Biologix, LLC

    XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.

    High risk
  21. Prime Vitality, Inc. dba Prime Peptides

    FDA warned Prime Peptides that its website sells Semaglutide and Retatrutide as unapproved new drugs for weight loss and diabetes.

    High risk
  22. Swisschems

    Swisschems sells Semaglutide and Retatrutide as unapproved new drugs despite research-chemical labeling.

    High risk
  23. Xcel Research LLC

    FDA warned Xcel Research for selling unapproved peptide drugs online with human-use claims.

    High risk
  24. Summit Research Peptides

    FDA warned Summit Research Peptides for selling unapproved semaglutide, retatrutide, cagrilintide, tirzepatide, and mazdutide with drug claims.

    High risk
  25. Veronvy

    FDA warned Veronvy that its Elily Veronvy weight-loss drops are unapproved new drugs and falsely labeled "FDA APPROVED."

    Medium
  26. Dr. Brite, LLC

    FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.

    High risk
  27. Applied Therapeutics, Inc.

    Applied Therapeutics, a trial sponsor, failed to let FDA access deleted electronic trial data and omitted dosing-error information from its drug application.

    High risk
  28. LCC Ltd.

    FDA warned LCC Ltd. over manufacturing-quality failures, contamination testing gaps, discarded lab data, and unapproved mouthwash drugs.

    High risk
  29. Centura Pharmaceuticals Inc

    FDA warned Centura Pharmaceuticals that its BLT 1-2-3 Cream, a mixed numbing product for cosmetic procedures, is an unapproved new drug.

    High risk
  30. Richard W. Foltin, Ph.D.

    FDA warned sponsor Dr. Richard W. Foltin for starting drug trials in people without an IND.

    High risk
  31. Frontier Biologics, LLC

    FDA warned Frontier Biologics of Waco, Texas, that its amniotic fluid and membrane products are unapproved drugs and unlicensed biologics.

    High risk
  32. Multaler et Cie SAS

    FDA cites Multaler et Cie for manufacturing failures and unapproved sunscreen after April 2024 inspection.

    High risk
  33. Fancy Drops Beauty LLC

    FDA says Fancy Drops Beauty sells unapproved eye drops claimed to change eye color.

    High risk
  34. Choice All Natural, Inc. dba Om Botanical

    FDA warns Om Botanical of Apex, NC over filthy manufacturing, an unapproved rash cream, and lapsed FDA registration.

    High risk
  35. Pinnacle Transplant Technologies, LLC

    FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.

    High risk
  36. Amnio Technology, LLC

    FDA warned Amnio Technology over unapproved injectable amniotic products and serious manufacturing deviations at its Phoenix facility.

    High risk
  37. Mexicanrxpharm.com

    FDA told Mexicanrxpharm.com to stop selling unapproved, misbranded opioid pain drugs to U.S. consumers online.

    High risk
  38. Supercore Products Group, Inc.

    FDA warns Supercore that Hard Steel and Gold Hard Steel Plus are unapproved, mislabeled drugs with hidden sildenafil; Hard Steel also has acetaminophen.

    High risk
  39. Little Moon Essentials, LLC

    FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.

    High risk
  40. Far East Summit LLC

    FDA says Far East Summit sold herbal supplements as unapproved drugs and made them under serious manufacturing violations.

    High risk
  41. Azurity Pharmaceuticals, Inc.

    FDA warned Azurity Pharmaceuticals over unapproved FIRST drug kits and manufacturing quality failures at its Wilmington, MA plant.

    High risk
  42. Nomida.biz

    FDA warned Nomida.biz over its website selling unapproved and misbranded semaglutide and tirzepatide drugs to U.S. consumers.

    High risk
  43. Aerosol and Liquid Packaging, Inc.

    FDA warns Aerosol and Liquid Packaging on CGMP failures and unapproved antiseptic spray claims.

    High risk
  44. Quality CDMO, Inc.

    FDA warned Quality CDMO that its prescription skin and scalp drugs are unapproved and lack FDA-approved applications.

    High risk
  45. Aromas Para El Alma S.A.

    Aromas Para El Alma, a Costa Rica drug manufacturer, made EREWHON hand sanitizer/spray subpotent and broke manufacturing rules.

    High risk
  46. EnviroServe Chemicals & Cleaners Ltd.

    EnviroServe's SOPURE hand sanitizer had manufacturing-quality violations and was sold as an unapproved, misleadingly labeled drug.

    High risk
  47. Root Bioscience Brands, LLC dba Naternal

    FDA warned Naternal that its CBD oils, gummies, and pet hemp oil are unapproved drugs due to drug claims.

    High risk
  48. Regenerative Processing Plant, LLC

    FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.

    High risk
  49. MexHealth LLC d/b/a Al Natural E-Shop

    FDA warned MexHealth LLC d/b/a Al Natural E-Shop that its Ossos-Sans supplement is an unapproved, misbranded drug containing hidden diclofenac and methocarbamol.

    High risk
  50. SoloVital

    FDA says SoloVital's Umary supplement is an unapproved, misbranded drug containing hidden diclofenac and omeprazole.

    High risk